SCL - Scales

[kiwi2007]

Highlights - 6 months to 30 June 2024 (1H24)

o Underlying NPAT Attributable to Shareholders of $28.5 million (1H23:
$14.5 million), up 97%
o Reported NPAT of $38.1 million (1H23: $14.3 million), up 167%
o Horticulture returning towards pre-Cyclone performance levels
o Global Proteins' performance consistent with 1H23
o Logistics benefiting from higher volumes
o Execution of strategic growth transactions in both Horticulture and Global
Proteins

Diversified agribusiness group Scales Corporation Limited (NZX:SCL) today
reported its 1H24 results with all divisions delivering strong earnings.

Decent set of half year results. No shocks.

[Waltzing]

well posted .

Its the one we have been waiting for to see if there is a sector of the economy that is going to get GDP back moving up.

Along with all land based industries...

Stats for export trade for this next 6 months are the ones to watch...

big long consolidated base line on that chart..

[winner (n)]

They say " Global Proteins' performance consistent with 1H23"

That's a bit disappointing .......pet stuff was going to be the real growth engine.

[winner (n)]

Slide 11 is interesting

https://api.nzx.com/public/announcement/436965/attachment/425792/436965-425792.pdf

Global proteins ... from H122 to H124 (2 years) volumes up ~60% but EBITDA about the same

Something not right here

[Sideshow Bob]

Slide 11 is interesting

https://api.nzx.com/public/announcement/436965/attachment/425792/436965-425792.pdf

Global proteins ... from H122 to H124 (2 years) volumes up ~60% but EBITDA about the same

Something not right here

Markets were strong during Covid, with plenty of demand, and good pricing. Manufacturers worried about supply chains, inventory, global shipping etc buying up.

More difficult post Covid, weaker demand and customers unwinding their stock positions. Meateor now got their plant in Australia, and other JV's, so probably accounts for the volume, but maybe these aren't performing so good yet?

[kiwi2007]

Highlights – 6 months to 30 June 2025 (1H25)

• Underlying NPATAS of $48.9 million (1H24: $28.5 million), up 72%
• Reported NPAT of $57.6 million (1H24: $38.1 million), up 51%
• Underlying EBITDA of $86.7m (1H24: $60.5m), up 43%
• All divisions successfully executing their respective growth strategies:
o Steady performance by the Global Proteins division
o Exceptional result by Horticulture
o Excellent result by Logistics
• Directors advise a further increase in FY25 Underlying NPATAS guidance to between $45.0m and $50.0m

Another set of good results from this great managemnt team.

[Umpah]

Big jump with SCL today 5.16 - 5.45 29c A good 5% market beginning to see the potential?

[Hectorplains]

Big jump with SCL today 5.16 - 5.45 29c A good 5% market beginning to see the potential?

SCL moves in fits because of its low liquidity.  Their trend line is good.  It looks slightly expensive to me but high growth expectations may justify that premium.

[Umpah]

Another jump from 5.35 to 5.69 on the back of their doubling their holdings in their Australian JVs amongst other things dog foods you've got to look after man's best friend They are doing a good job of diversifying away from NZ horticulture and the vagaries of climatic events

[Umpah]

Good market update today if anyone's interested increase of about 10% on NPAT

[Left Field]

Outstanding result..... well done holders

https://www.nzx.com/announcements/468113

Diversified agribusiness group Scales Corporation Limited (NZX:SCL) today reported its FY2025 full year results. Reported NPAT Attributable to Shareholders was $101.0 million (FY2024 (restated) : $30.3 million). Reported basic earnings per share for FY2025 were 70.7 cents per share
 (FY2024 (restated): 21.3 cents per share).
 
 Underlying NPAT Attributable to Shareholders was $61.8 million (FY2024 (restated): $34.1 million) and Underlying earnings per share for FY2025 were 43.3 cents per share (FY2024 (restated): 24.0 cents per share).
 
 • Group FY2025 financial results:
 o Underlying NPAT of $77.6 million, up 45 per cent (FY2024 (restated): $53.4 million)
 o Reported NPAT of $117.7 million, up 137 per cent (FY2024 (restated): $49.6 million)
 o Underlying EBITDA of $137.6 million, up 50 per cent (FY2024 (restated): $91.7 million)
 o Revenue of $899.9 million, up 54 per cent (FY2024: $584.6 million)

....."Accordingly, the Board is pleased to confirm the previously advised FY2026 guidance of Underlying Net Profit after Tax Attributable to Shareholders of between $50.0 million to $55.0 million, implying an Underlying Net Profit After Tax range of $67.0 million to $73.0 million and an Underlying EBITDA range of $129.0 million to $136.0 million."